GWAS HUMANOMNIEXPRESS + EXOME FOR NCI (PETERS)

NCI 的 GWAS HUMANOMNIEXPRESS 外显子组 (PETERS)

• 批准号: 8759356
• 负责人: SONIA DUA
• 金额: $ 153.9万
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8759356
• 关键词: Animal Model; Arthritis; Child; Child health care; Contracts; Diabetes Mellitus; Digestive System Disorders; Disease; Extramural Activities; Funding; Genetic Medicine; Genetic Services; Genotype; Government; Grant; Human Development; Inherited; Institutes; Kidney Diseases; Musculoskeletal Diseases; NIH Program Announcements; National Cancer Institute; National Eye Institute; National Human Genome Research Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Dental and Craniofacial Research; National Institute of Drug Abuse; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute on Deafness and Other Communication Disorders; Peer Review; Principal Investigator; Process; Qualifying; Research; Scientist; Services; Support Contracts; United States National Institutes of Health; Universities; exome; genome wide association study; human disease; programs; skin disorder

The Center for Inherited Disease Research (CIDR) is a centralized facility that provides genotyping, sequencing and statistical genetics services for qualifying National Institutes of Health (NIH)-funded projects. These services are available to extramural and intramural scientists supported by the institutes participating in the CIDR program. CIDR's main focus is high-throughput projects relating to human disease. However, some smaller projects and projects involving model organisms can also be accommodated. Currently, 14 NIH institutes participate: The National Cancer Institute (NCI); the National Eye Institute (NEI); the National Human Genome Research Institute (NHGRI); the National Institute on Aging (NIA); the National Institute on Alcohol Abuse and Alcoholism (NIAAA); the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); the National Institute of Child Health and Human Development (NICHD); the National Institute on Drug Abuse (NIDA); the National Institute on Deafness and Other Communication Disorders (NIDCD); the National Institute of Dental and Craniofacial Research (NIDCR); the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); the National Institute of Environmental Health Sciences (NIEHS); the National Institute of Mental Health (NIMH), and the National Institute of Neurological Disorders and Stroke (NINDS). Access to CIDR is granted via a peer review process (NIH program announcement: PAR 11-210). The facility is supported through a five-year, $115 million federal contract (number N01-HG-72096) to The Johns Hopkins University (JHU) with Dr. David Valle of the JHU Institute of Genetic Medicine as Principal Investigator. Dr. Lawrence C. Brody of the National Human Genome Research Institute (NHGRI) serves as CIDR's Chief Scientific Officer. Ms. Gloria Dunnigan, NHGRI, serves as the government Project Officer. Dr. Camilla Day, NHGRI, serves as Scientific Review Officer and Executive Director of the CIDR Board of Governors.

遗传疾病研究中心（CIDR）是一个集中的机构，为合格的美国国立卫生研究院（NIH）资助的项目提供基因分型，测序和统计遗传学服务。这些服务提供给参加CIDR方案的研究所支持的校外和校内科学家。CIDR的主要重点是与人类疾病有关的高通量项目。但是，也可以容纳一些较小的项目和涉及模式生物的项目。 目前有14个国家卫生研究所参加：国家癌症研究所、国家眼科研究所、国家人类基因组研究所、国家老龄问题研究所、国家酗酒和酒精中毒研究所、国家关节炎、肌肉骨骼和皮肤病研究所、国家儿童健康和人类发展研究所;国家药物滥用研究所（NIDA）;国家耳聋和其他交流障碍研究所（NIDCD）;国家牙科和颅面研究所（NIDCR）;国家糖尿病、消化和肾脏疾病研究所（NIDDK）;国家环境健康科学研究所（NIEHS）;国家精神卫生研究所（NIMH）和国家神经疾病和中风研究所（NINDS）。通过同行评审程序授予CIDR访问权限（NIH计划公告：PAR 11-210）。 该设施是通过一个为期五年，1.15亿美元的联邦合同（编号N 01-HG-72096），以约翰霍普金斯大学（JHU）与遗传医学研究所的大卫瓦莱博士作为首席研究员的支持。劳伦斯·C博士国家人类基因组研究所（NHGRI）的布罗迪担任CIDR的首席科学官。NHGRI的格洛丽亚邓尼根女士担任政府项目干事。Camilla Day博士，NHGRI，担任CIDR理事会的科学审查官员和执行董事。